Eric Goslau

President, CEO, Co-Founder, Co-Inventor, Board Director

Therapeutic Areas

Drug	Indication	Phase
POINT-GUARD™	Cerebral embolic protection during Transcatheter Aortic Valve Replacement (TAVR)	Pre-clinical